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Abstract: Our case illustrates the first report of an HIV-infected patient with a nasopharyngeal squamous cell carcinoma 
with viremia by one Epstein-Barr virus (EBV) and seropositivity by two high risk oncogenic human papilloma viruses 
(HPV)-types (HPV-16 and HPV-33), previous to his death. This patient presented a fatal fast-evolution. 
CASE REPORT 
  A 38 year-old man diagnosed with HIV in 1987 (dis-
seminated tuberculosis) and HCV, who was an ex-IDU, 
smoker (30 cigarettes per day), and alcohol consumer (30 
g/day), with poor HAART adherence, and a CD4 nadir of 6 
cells/mm
3 in 2005, was seen on April 20
th 2006 in a routine 
HIV control. He reported having an oppressive headache in 
the last week. The exploration only showed hypoesthesia in 
the right side of the face. A small ulcer in the cavum and an 
exophytic polypoid lesion in the back and upper area of the 
right nostril were observed by nasopharyngoscopy. Com-
puted tomography visualized a mass in the cavum. A biopsy 
diagnosed a moderately differentiated squamous cell cancer. 
P.E.T. showed a hypermetabolic mass from the skull base to 
the right jawbone (Fig. 1). In addition, P.E.T. also showed 
infiltration in the latero-cervical, supra clavicular and para-
oesophagus nodes, in C3 and C6 (cervical vertebras), and in 
the liver (not shown). The patient restarted HAART on May 
9
th and was discharged. The patient was readmitted to the 
hospital on June 6
th and he died one week later because of 
liver failure. The patient signed the informed consent to 
study HPV (June 6
th) and his family authorized to publish 
this event. 
  Epstein-Barr Virus (EBV) and Human Papilloma Virus 
(HPV) were studied in biopsy and in blood serum sample 
(June 6
th) by PCR real time and multiplex PCR kit, respec-
tively. Furthermore, HPV was analyzed in samples from the 
oral cavity, anus, and penis. EBV was positive in the biopsy 
and in serum (63000 copies/mL) and HPV was positive in 
serum for two high risk oncogenic types: HPV-16 and HPV-
33. HPV was also detected in the anus (HPV-16 and HPV-
51) and in the penis (HPV-51). 
  We believe that our case illustrates the first report of an 
HIV-infected patient with a nasopharyngeal squamous cell 
carcinoma with a viremia by one EBV and two high risk 
oncogenic HPV-types, previous to his death. Although EBV 
appears to be the most important etiological factor for the  
 
 
*Address correspondence to this author at the Lluita Contra La SIDA Foun-
dation; Hospital Universitari Germans Trias i Pujol; Badalona, Barcelona-
08916, Spain; Fax: (34) 93 465 76 02; E-mail: svidela@esteve.es 
 
Fig. (1). P.E.T. showed a hypermetabolic mass from the skull base 
to the right jawbone. 
development of nasopharyngeal cancer and its presence in 
serum suggests metastasis [1,2], the HPV has been also im-
plicated as an etiological factor in a subset of head and neck 
squamous cell carcinomas (HNSCC), and its presence in the 
sera has been related with an advanced HNSCC stage, or 
with a high risk for metastasis and with a poor prognosis [3-
5]. Although we did not find HPV in the biopsy, we cannot 
dismiss its presence [3]. Moreover, he was HPV seropositive 
which could mean that the tumor was the source for it. The 
serum sample studied could only represent a single time 
point during the patient’s care, however HPV DNA in serum 
may represent occult haematogenous spread of cancer cells. 
So, it may be acceptable that the origin of the serum HPV 
could be the tumor. 2    The Open AIDS Journal, 2008, Volume 2  Sirera et al. 
  Patients with HPV-positive tumors have a better overall 
survival than patients with HPV-negative tumors [4]. It has 
been observed that a normal host immunity may block me-
tastatic disease [3]. So, the rapid evolution observed could be 
mainly related to the severe immunodeficiency HIV related. 
Indeed, the widespread metastatic lesions suggest the expres-
sion of chemokine receptor CXCR4 which has been associ-
ated with a high rate of metastatic potential of human naso-
pharyngeal carcinoma [6]. Likewise, other risk factors such 
as being smoker and an alcohol consumer could contribute to 
the aggressive clinical outcome as well. 
  In summary, this case suggests that in very advanced 
HIV patients with severe immunodeficiency, tumors may 
have a rapid evolution and different viruses etiologically 
related (HPV and EBV) can be detected in blood which 
could be associated with a worse and rapid outcome. 
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